Luyan PharmaLtd Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Luyan PharmaLtd has a total shareholder equity of CN¥3.1B and total debt of CN¥5.0B, which brings its debt-to-equity ratio to 161.7%. Its total assets and total liabilities are CN¥12.4B and CN¥9.3B respectively. Luyan PharmaLtd's EBIT is CN¥705.6M making its interest coverage ratio 3.2. It has cash and short-term investments of CN¥481.5M.
Belangrijke informatie
161.7%
Verhouding schuld/eigen vermogen
CN¥5.01b
Schuld
| Rente dekkingsratio | 3.2x |
| Contant | CN¥481.54m |
| Aandelen | CN¥3.10b |
| Totaal verplichtingen | CN¥9.30b |
| Totaal activa | CN¥12.40b |
Recente financiële gezondheidsupdates
Geen updates
Analyse van de financiële positie
Kortlopende schulden: 002788's short term assets (CN¥9.7B) exceed its short term liabilities (CN¥8.4B).
Langlopende schulden: 002788's short term assets (CN¥9.7B) exceed its long term liabilities (CN¥868.5M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 002788's net debt to equity ratio (146.1%) is considered high.
Schuld verminderen: 002788's debt to equity ratio has reduced from 176.7% to 161.7% over the past 5 years.
Schuldendekking: 002788's debt is not well covered by operating cash flow (17.3%).
Rentedekking: 002788's interest payments on its debt are well covered by EBIT (3.2x coverage).